Nanosphere Wins FDA Clearance to Market CYP2C19 Mutations Detection Test

Nanosphere, Inc.

announced today the US FDA granted 510(k) clearance permitting marketing of its CYP2C19 Nucleic Acid Test (CYP2C19 Test) on the automated sample-to-result Verigene^® System.